Exparel 1.3% injectable suspension Images
Generic Name: bupivacaine liposome
This medication has been identified as Exparel 1.3% injectable suspension. It is supplied by Pacira BioSciences, Inc.
Exparel is used in the treatment of Postoperative Pain; Pain and belongs to the drug class local injectable anesthetics. Risk cannot be ruled out during pregnancy. Exparel 1.3% injectable suspension is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Exparel
- Generic Name
- bupivacaine liposome
- Strength
- 1.3% injectable suspension
- Availability
- Prescription only
- Drug Class
- Local injectable anesthetics
- Pregnancy Category
- C - Risk cannot be ruled out
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Pacira BioSciences, Inc.
- National Drug Code (NDC)
More about Exparel (bupivacaine liposome)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (71)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: local injectable anesthetics
- En español
Patient resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
